Moderna recently announced that Arpa Garay will join the company as chief commercial officer, effective May 31, 2022.
Garay joins Modera from Merck & Co, where she became an expert in oncology,...
Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressant drugs that treat depression and other mental health conditions by inhibiting the reabsorption of serotonin by neurons in the brain.
According to the National...
GSK recently entered into a $1.9 billion agreement to acquire biopharmaceutical company Sierra Oncology to treat rare cancers.
Myelofibrosis is a rare blood cancer that causes considerable...
Because the past few centuries have witnessed several revolutionary scientific advances, research into the mechanisms responsible for infectious diseases and the development of drugs and vaccines has led to the eradication of...
Sanofi recently launched its first-in-pharma Diversity, Equity, & Inclusion (DE&I) Board to encourage an inclusive and diverse culture that enables breakthrough innovations.
The...
Sandoz, a Novartis division, recently acquired a UK-based medical and drug delivery device company, Coalesce Product Development Limited.
Through the terms of the agreement, Sandoz...
Thermo Fisher Scientific will invest $97 million to expand its clinical research operations in Virginia to support the increasing demand for drug development.
Over the next three years,...
Although there has been increasing public interest in studying scheduled drugs, most scientists are reluctant to conduct studies on Schedule I substances because of unreasonably burdensome rules and regulations enforced by the Drug...
Novo Nordisk recently expanded its research collaboration in oral drug delivery technologies with the Massachusetts Institutes of Technology (MIT) and Brigham and Women’s Hospital...
FDA recently issued three final guidance documents to the industry regarding cancer clinical trials that parallel the goals of President Biden’s effort to renew and rebuild upon his 2016 Cancer...
Clinical trials are an integral part of new product discovery and development. These trials (or clinical studies) test and assess potential treatments such as drugs, medical devices, or biologics (vaccines, gene and cellular therapies,...
AstraZeneca Rare Disease and Alexion group recently closed a global collaboration and license agreement with Neurimmune AG for the investigational human monoclonal antibody, NI006.
NI006 is a...
GSK recently announced that the consumer healthcare company from its proposed transaction with Pfizer will be named Haleon.
Haleon will be a new world leader in consumer healthcare, offering to bring...
Merck KGaA, Darmstadt, Germany, and Quris recently signed an agreement to assess the Quris BioAI machine learning platform and compare it to traditional in vitro and in vivo approaches.
The Quris...
Biogen and Xbrane Biopharma recently agreed to develop, manufacture, and commercialize a preclinical monoclonal antibody and proposed biosimilar, Xcimzane, referencing Cimzia.
Cimzia is a drug...
The Senate recently confirmed Robert Califf as FDA Commissioner after the Biden administration nominated him in early November, according to multiple outlets.
The final vote was 50 to 46, with six GOP...
The FDA recently issued draft guidance to foster the development of non-addictive alternatives to opioids to manage acute pain and prevent new addiction.
The guidance provides recommendations to...
ViiV Healthcare, GSK, and Shionogi recently entered a $1.25-billion settlement over the global patent infringement litigation with Gilead concerning its HIV drug combined with three HIV integrase...
Abbott recently announced the world's first implant of a dual-chamber leadless pacemaker system as part of its Aveir DR i2i pivotal clinical trial.
The prospective investigational study will...
Biogen recently exercised its option to participate in the development and commercialization of Genentech’s bispecific antibody, mosunetuzumab.
Mosunetuzumab is a CD20xCD3 T-cell engaging...
